Centric Health Corp. (TSE:CRX – Free Report) – Analysts at Desjardins decreased their FY2024 earnings per share (EPS) estimates for shares of Centric Health in a research report issued on Sunday, November 10th. Desjardins analyst G. Ho now forecasts that the company will earn ($0.03) per share for the year, down from their prior estimate of ($0.02).
A number of other research analysts have also issued reports on CRX. Stifel Canada lowered shares of Centric Health from a “strong-buy” rating to a “hold” rating in a report on Monday, August 12th. Ventum Cap Mkts raised shares of Centric Health to a “strong-buy” rating in a research note on Thursday, August 8th.
Centric Health Stock Performance
Recommended Stories
- Five stocks we like better than Centric Health
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Home Depot Stock: Targeting 12% in 2024 and 25% More in 2025
- How to Calculate Inflation Rate
- Is Tesla’s Valuation a Bubble or Backed by Real Growth?
- Roth IRA Calculator: Calculate Your Potential Returns
- Trucking Stocks Led the Pack Last Week: Can They Keep Rolling?
Receive News & Ratings for Centric Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centric Health and related companies with MarketBeat.com's FREE daily email newsletter.
